172 related articles for article (PubMed ID: 26279304)
1. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
Jen J; Lin LL; Chen HT; Liao SY; Lo FY; Tang YA; Su WC; Salgia R; Hsu CL; Huang HC; Juan HF; Wang YC
Oncogene; 2016 May; 35(18):2357-69. PubMed ID: 26279304
[TBL] [Abstract][Full Text] [Related]
2. AKT-mediated phosphorylation enhances protein stability and transcription activity of ZNF322A to promote lung cancer progression.
Liao SY; Kuo IY; Chen YT; Liao PC; Liu YF; Wu HY; Lai WW; Wang YC
Oncogene; 2019 Oct; 38(41):6723-6736. PubMed ID: 31399647
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.
Lin CC; Kuo IY; Wu LT; Kuan WH; Liao SY; Jen J; Yang YE; Tang CW; Chen YR; Wang YC
Theranostics; 2020; 10(22):10001-10015. PubMed ID: 32929330
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression.
Jen J; Liu CY; Chen YT; Wu LT; Shieh YC; Lai WW; Wang YC
Cell Death Differ; 2019 Jul; 26(7):1283-1298. PubMed ID: 30258097
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-326 enhances ZNF322A expression, transcriptional activity and tumorigenic effects in lung cancer.
Huang SH; Hsieh HC; Shieh JM; Su WC; Wang YC
Biofactors; 2024; 50(1):214-227. PubMed ID: 37647209
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer.
Ming J; Jiang G; Zhang Q; Qiu X; Wang E
Cancer Immunol Immunother; 2012 Jan; 61(1):79-88. PubMed ID: 21847632
[TBL] [Abstract][Full Text] [Related]
7. CK1δ/GSK3β/FBXW7α axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression.
Liao SY; Chiang CW; Hsu CH; Chen YT; Jen J; Juan HF; Lai WW; Wang YC
Oncogene; 2017 Oct; 36(41):5722-5733. PubMed ID: 28581525
[TBL] [Abstract][Full Text] [Related]
8. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
9. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
You W; Chen B; Liu X; Xue S; Qin H; Jiang H
Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
[TBL] [Abstract][Full Text] [Related]
11. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
Jen J; Lin LL; Lo FY; Chen HT; Liao SY; Tang YA; Su WC; Salgia R; Hsu CL; Huang HC; Juan HF; Wang YC
Oncogene; 2017 Sep; 36(36):5219. PubMed ID: 28628114
[TBL] [Abstract][Full Text] [Related]
12. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer.
Jen J; Lin LL; Lo FY; Chen HT; Liao SY; Tang YA; Su WC; Salgia R; Hsu CL; Huang HC; Juan HF; Wang YC
Oncogene; 2017 Aug; 36(31):4526. PubMed ID: 28368404
[TBL] [Abstract][Full Text] [Related]
13. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
14. ZNF322A-mediated protein phosphorylation induces autophagosome formation through modulation of IRS1-AKT glucose uptake and HSP-elicited UPR in lung cancer.
Cheung CHY; Hsu CL; Lin TY; Chen WT; Wang YC; Huang HC; Juan HF
J Biomed Sci; 2020 Jun; 27(1):75. PubMed ID: 32576196
[TBL] [Abstract][Full Text] [Related]
15. Homeobox Transcription Factor NKX2-1 Promotes
Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
[TBL] [Abstract][Full Text] [Related]
16. Adducins inhibit lung cancer cell migration through mechanisms involving regulation of cell-matrix adhesion and cadherin-11 expression.
Lechuga S; Amin PH; Wolen AR; Ivanov AI
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):395-408. PubMed ID: 30290240
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
[TBL] [Abstract][Full Text] [Related]
18. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
19. BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells.
Nakuci E; Mahner S; Direnzo J; ElShamy WM
Exp Cell Res; 2006 Oct; 312(16):3120-31. PubMed ID: 16860316
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
